Stephen Nishimura

Stephen Nishimura

Company: University of California San Francisco

Job title: Professor & Chief of Pathology

Seminars:

Discover the Potential of Integrin Inhibitors to Selectively Block TGF-β 3:30 pm

• Assessing the potential to avoid off-target effects and toxicity caused by un-selective targeting of TGF-β • Realizing a more selective approach to targeting TGF-β through integrins • Safely and effectively overcome TGF-β driven immuno-suppression in the tumorRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.